BioCentury
ARTICLE | Clinical News

Oramed Insulin Capsule: Phase IIa data

November 3, 2014 8:00 AM UTC

Top-line data from a double-blind, placebo-controlled, U.S. Phase IIa trial in 25 Type I diabetics showed that oral ORMD-0801 given before meals was well tolerated. Oramed said the trial was not power...